Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Milestone Scientific (MLSS)

Milestone Scientific (MLSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion GlobeNewswire - Mon Feb 23, 7:30AM CST

ROSELAND, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision,...

MLSS : 0.2748 (-4.58%)
Milestone Scientific Launches The Wand® Ambassador Program to Expand Peer Engagement and Accelerate Market Adoption in Dentistry GlobeNewswire - Tue Jan 6, 7:30AM CST

ROSELAND, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections,...

MLSS : 0.2748 (-4.58%)
Milestone Scientific Delivers Stable Revenue and Reduces Operating Expenses by Over $500 Thousand in the Third Quarter of 2025 GlobeNewswire - Thu Nov 13, 2025

ROSELAND, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections,...

MLSS : 0.2748 (-4.58%)
Milestone Scientific Schedules Third Quarter 2025 Financial Results and Business Update Conference Call GlobeNewswire - Thu Nov 13, 2025

ROSELAND, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS),  a leading developer of computerized drug delivery instruments, that provide painless and precise injections,...

MLSS : 0.2748 (-4.58%)
Milestone Scientific Faces NYSE Non-Compliance Notice Tipranks - Wed Oct 15, 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Milestone...

MLSS : 0.2748 (-4.58%)
Milestone Scientific Highlights Operational Progress and Growth Initiatives Under New Leadership GlobeNewswire - Tue Oct 14, 2025

ROSELAND, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections,...

MLSS : 0.2748 (-4.58%)
Milestone Scientific Commits to Regaining NYSE American Compliance Following Notification GlobeNewswire - Tue Oct 14, 2025

ROSELAND, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections,...

MLSS : 0.2748 (-4.58%)
Milestone Scientific Appoints Dr. Dawood Sayed to Board of Directors to Advance Commercial and Clinical Strategy in Pain Management GlobeNewswire - Mon Sep 22, 2025

ROSELAND, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections,...

MLSS : 0.2748 (-4.58%)
Milestone Scientific Achieves 25% Increase in Revenue for the Second Quarter of 2025 GlobeNewswire - Thu Aug 14, 2025

ROSELAND, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections,...

MLSS : 0.2748 (-4.58%)
Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call GlobeNewswire - Wed Aug 13, 2025

ROSELAND, N.J., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections,...

MLSS : 0.2748 (-4.58%)

Barchart Exclusives

What Options Traders Expect from Micron Stock After Earnings on March 18 Barchart - 36 minutes ago
Micron shares are in focus ahead of the company’s Q2 earnings on March 18. RBC analyst recommends buying MU stock heading into the second-quarter release. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot